[1]
Kouassi, K.K.Y. et al. 2025. Trastuzumab and Pertuzumab in HER2-Positive Metastatic Breast Cancer in West Africa: A Retrospective Cohort Study from Côte d’Ivoire: Study HER2-Breast-CIV. Archives of Breast Cancer. 12, 4 (Oct. 2025), 419–425. DOI:https://doi.org/10.32768/abc.8472051937-468.